Search research articles
Contact Us
Filters
Showing results (611-620 of 657) with videos related to
Page
of 66
Sort By:
Cell Research
|
October 20, 2010
Generation of iPSCs from mouse fibroblasts with a single gene, Oct4, and small molecules
Yanqin Li, Qiang Zhang, Xiaolei Yin, et al.
BMC Medicine
|
May 2, 2026
Impact of a real-time automatic quality control system for magnetically controlled capsule gastroscopy: a multicenter randomized controlled trial
Xiaoya Wang, Dawei Shen, Yusha Zhao, et al.
Frontiers in Pediatrics
|
February 10, 2022
Association Between NT-proBNP and Prolonged Length of Stay in Hospital Among Preterm Infants Born at 28-31 Weeks' Gestation
Jian Ge, Chenghan Luo, Mengyuan Lei, et al.
American Journal of Cancer Research
|
December 2, 2016
Volasertib suppresses the growth of human hepatocellular carcinoma <i>in vitro</i> and <i>in vivo</i>
Di-Wei Zheng, You-Qiu Xue, Yong Li, et al.
Nature Communications
|
July 9, 2015
Netrin-1 regulates somatic cell reprogramming and pluripotency maintenance
Duygu Ozmadenci, Olivier Féraud, Suzy Markossian, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
May 28, 2020
Tetramethylpyrazine attenuates endotoxin-induced retinal inflammation by inhibiting microglial activation via the TLR4/NF-κB signalling pathway
Xiaokun Han, Xi Chen, Shuilian Chen, et al.
American Journal of Cancer Research
|
February 18, 2016
Volasertib suppresses tumor growth and potentiates the activity of cisplatin in cervical cancer
Feng-Feng Xie, Shi-Shi Pan, Rong-Ying Ou, et al.
American Journal of Cancer Research
|
January 26, 2016
Sildenafil inhibits the growth of human colorectal cancer in vitro and in vivo
Xiao-Long Mei, Yang Yang, Yao-Jun Zhang, et al.
Frontiers in Oncology
|
May 2, 2022
TIM-3 Expression Level on AML Blasts Correlates With Presence of Core Binding Factor Translocations Rather Than Clinical Outcomes
Jian Hong, Leiming Xia, Zhenqi Huang, et al.
European Journal of Pharmacology
|
February 13, 2021
Discovery of a highly potent kinase inhibitor capable of overcoming multiple imatinib-resistant ABL mutants for chronic myeloid leukemia (CML)
Tingting Lu, Jiangyan Cao, Fengming Zou, et al.
Page
of 66
Search research articles
Search
Showing results (611-620 of 657) with videos related to
Sort By:
Page
of 66
Cell Research
|
October 20, 2010
Generation of iPSCs from mouse fibroblasts with a single gene, Oct4, and small molecules
Yanqin Li, Qiang Zhang, Xiaolei Yin, et al.
BMC Medicine
|
May 2, 2026
Impact of a real-time automatic quality control system for magnetically controlled capsule gastroscopy: a multicenter randomized controlled trial
Xiaoya Wang, Dawei Shen, Yusha Zhao, et al.
Frontiers in Pediatrics
|
February 10, 2022
Association Between NT-proBNP and Prolonged Length of Stay in Hospital Among Preterm Infants Born at 28-31 Weeks' Gestation
Jian Ge, Chenghan Luo, Mengyuan Lei, et al.
American Journal of Cancer Research
|
December 2, 2016
Volasertib suppresses the growth of human hepatocellular carcinoma <i>in vitro</i> and <i>in vivo</i>
Di-Wei Zheng, You-Qiu Xue, Yong Li, et al.
Nature Communications
|
July 9, 2015
Netrin-1 regulates somatic cell reprogramming and pluripotency maintenance
Duygu Ozmadenci, Olivier Féraud, Suzy Markossian, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
May 28, 2020
Tetramethylpyrazine attenuates endotoxin-induced retinal inflammation by inhibiting microglial activation via the TLR4/NF-κB signalling pathway
Xiaokun Han, Xi Chen, Shuilian Chen, et al.
American Journal of Cancer Research
|
February 18, 2016
Volasertib suppresses tumor growth and potentiates the activity of cisplatin in cervical cancer
Feng-Feng Xie, Shi-Shi Pan, Rong-Ying Ou, et al.
American Journal of Cancer Research
|
January 26, 2016
Sildenafil inhibits the growth of human colorectal cancer in vitro and in vivo
Xiao-Long Mei, Yang Yang, Yao-Jun Zhang, et al.
Frontiers in Oncology
|
May 2, 2022
TIM-3 Expression Level on AML Blasts Correlates With Presence of Core Binding Factor Translocations Rather Than Clinical Outcomes
Jian Hong, Leiming Xia, Zhenqi Huang, et al.
European Journal of Pharmacology
|
February 13, 2021
Discovery of a highly potent kinase inhibitor capable of overcoming multiple imatinib-resistant ABL mutants for chronic myeloid leukemia (CML)
Tingting Lu, Jiangyan Cao, Fengming Zou, et al.
Page
of 66